Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...

Related Keywords

Canada ,United Kingdom ,David Szekeres ,Centers For Medicare Medicaid Services ,Prnewswire Heron Therapeutics Inc ,European Commission ,Drug Administration ,Nasdaq ,Hospital Outpatient Department ,Exchange Commission ,European Union ,Surgical Center ,Health Canada ,Heron Therapeutics Inc ,Hospital Outpatient ,Ambulatory Surgical Center ,Medicaid Services ,Average Sales Price ,Barry Quart ,Chief Executive Officer ,Safety Information ,Prescribing Information ,European Economic Area ,Boxed Warning ,Heron Therapeutics ,Private Securities Litigation Reform Act ,Coronavirus Disease ,Media Contact ,Vice President ,Chief Operating ,Nc ,